Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TALONX RESOURCES LIMITED AGM Information 2020

Oct 29, 2020

65972_rns_2020-10-29_ac53a834-e44b-4e1e-9189-29a4557ad255.pdf

AGM Information

Open in viewer

Opens in your device viewer

==> picture [220 x 81] intentionally omitted <==

30 October 2020

Dear Shareholder,

NOTICE TO SHAREHOLDERS RE MOUNT BURGESS MINING ANNUAL GENERAL MEETING

The 2020 Annual General Meeting of the shareholders of Mount Burgess Mining N.L. (ACN 009 067 476) (“the Company”) will be held via virtual technology on 30 November 2020 at 2.30 pm Perth time.

The Company is aware of the current circumstances resulting from COVID-19 and social distancing restrictions that apply currently in Western Australia. The health and safety of our members, directors and staff and other personnel is our highest priority. Therefore, based on the best information available to the Board at the time of this Notice to Shareholders, the Company intends to conduct its AGM by way of a live video conference. Shareholders are strongly encouraged to vote by lodging a directed proxy appointing the Chair as early as possible and in any event prior to the cut-off for proxy voting as set out in the Notice of Meeting (being 2.30 pm Perth Time on 28 November 2020). Instructions for lodging proxies are included on your personalised proxy form enclosed with this letter.

In accordance with Corporations (Coronavirus Economic Response) Determination (No. 3) 2020 issued by the Federal Treasurer on 21 September 2020, the Company’s Notice of Annual General Meeting, accompanying Explanatory Statement and any Schedules (“Meeting Materials”) are being made available to shareholders electronically.

Shareholders will be able to view and download the Meeting Materials online from the Company’s website at www.mountburgess.com If you have nominated an email address with the Company’s Share Registry, Advanced Share Registry Services, and have elected to receive electronic communications you will receive an email to your nominated email address with a link to the electronic copy of the Meeting Materials.

Participation in the virtual meeting and electronic voting will be offered through advancedshare.com.au/virtual-meeting. Please refer to the Meeting ID and Shareholder ID on your proxy form to login to the website.

Discussion will be held on all items to be considered at the AGM and shareholders will have a reasonable opportunity to ask questions during the AGM via the virtual AGM platform, including an opportunity to ask questions of the Company’s external auditor. Shareholder questions should be stated clearly and should be relevant to the business of the meeting, including matters arising from the Financial Report, Directors’ Report (including the Remuneration Report) and Auditor’s Report or any of the other AGM Resolutions as listed on the Notice of Annual General Meeting. Shareholders can login to the virtual meeting portal and ask question online under the Q&A section.

All resolutions for the 2020 Annual General Meeting will be decided on a poll (based on votes submitted by proxy and by Shareholders who have indicated they intend voting at the meeting). Advanced Share Registry Services will be facilitating the voting. We strongly encourage shareholders to submit their proxies as early as possible. We recommend logging into the online platform at least 15 minutes prior to the scheduled start time for the AGM using the instructions provided

Yours sincerely,

==> picture [162 x 32] intentionally omitted <==

Jan Forrester Company Secretary

Note: In the event of a major communications break down once the Virtual Meeting is underway and one that cannot quickly be fixed, the Company will adjourn the meeting and shareholders should check at the Company’s website the time for the adjourned meeting.

ACN: 009 067 476 8/800 Albany Hwy East Victoria Park Western Australia 6101 Tel: (61 8) 9355 0123 Fax: (61 8) 9355 1484 [email protected] www.mountburgess.com

==> picture [196 x 72] intentionally omitted <==

ACN: 009 067 476

NOTICE OF ANNUAL GENERAL MEETING

The 2020 Annual General Meeting of Mount Burgess Mining N.L will be held as a Virtual Meeting at 2.30 pm Western Australia time on Monday 30 November 2020

AGENDA

BUSINESS

An Explanatory Statement containing information in relation to each of the following Resolutions accompanies this Notice of Annual General Meeting

GENERAL BUSINESS

Financial Report for the Year ended 30 June 2020

To receive the financial statements, Directors’ report and auditor’s report for Mount Burgess Mining NL and its controlled entities for the year ended 30 June 2020.

ORDINARY RESOLUTIONS

1 - Adoption of Remuneration Report

“That, for the purpose of Section 250R(2) of the Corporations Act and for all other purposes, approval is given for the adoption of the remuneration report as contained in the Company’s annual financial report for the financial year ended 30 June 2020”

Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.

Voting Exclusion Statement:

In accordance with section 250R (4) of the Act, no member of the key management personnel of the Company or a closely related party of such a member may vote on Resolution 1.

However, in accordance with the Act, a person described above may vote on Resolution 1 if:

• It is cast by such person as proxy for a person who is permitted to vote, in accordance with the direction specified on the proxy form how to vote; or

• It is cast by the Chairman as proxy for a person who is permitted to vote, in accordance with an express direction specified on the proxy form to vote as the proxy decides.

Chairman appointed as proxy:

If the Chairman is appointed as a proxy for a person who is permitted to vote on this Resolution 1, the Chairman will vote any proxies which do not indicate on their proxy form the way the Chairman must vote, in favour of Resolution 1.

2 - Ratification of Previous Issue of Securities to Sophisticated and Professional Investors – November 2019 made under Listing Rule 7.1

To consider and, if thought fit, pass the following as an ordinary resolution :

“that for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders approve and ratify the issue of 12,000,000 shares to Sophisticated and Professional investors at 0.25 of one cent each, for the purpose and terms set out in the Explanatory Statement which accompanies the notice convening this meeting.”

1

  • (The Company will disregard any votes cast in favour of the resolution by or on behalf of:

  • any person who participated in the issue or

  • an associate of that person.

However, the Company need not disregard a vote if:

  • it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or

  • it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

3 - Ratification of Previous Issue of Securities to Sophisticated and Professional Investors – March 2020 made under Listing Rule 7.1

To consider and, if thought fit, pass the following as an ordinary resolution :

“that for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders approve and ratify the issue of 35,333,333 shares to Sophisticated and Professional investors at 0.15 of one cent each, for the purpose and terms set out in the Explanatory Statement which accompanies the notice convening this meeting.”

(The Company will disregard any votes cast in favour of the resolution by or on behalf of:

  • any person who participated in the issue or

  • an associate of that person.

However, the Company need not disregard a vote if:

  • it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or

  • it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

4 - Ratification of Previous Issue of Securities to Sophisticated and Professional Investors – July 2020 made under Listing Rule 7.1

To consider and, if thought fit, pass the following as an ordinary resolution :

“that for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders approve and ratify the issue of 30,686,075 shares to Sophisticated and Professional investors at 0.15 of one cent each, for the purpose and terms set out in the Explanatory Statement which accompanies the notice convening this meeting.”

(The Company will disregard any votes cast in favour of the resolution by or on behalf of:

  • any person who participated in the issue or

  • an associate of that person.

However, the Company need not disregard a vote if:

  • it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form; or

  • it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

5 - Re-election of Director – Mr Chris Campbell-Hicks

To consider and, if thought fit, pass the following as an ordinary resolution :

“That, for all purposes, Mr Chris Campbell-Hicks, who retires in accordance with Listing Rule 14.4 and Clause 13.6 of the Constitution, being eligible and offering himself for re-election, be elected as a Director of the Company with immediate effect.”

6 - Issue of Shares to a Director in lieu of Directors’ Fees – Ms K A Clark

To consider and, if thought fit, to pass the following as an ordinary resolution :

“That, for the purposes of Section 208 of the Corporations Act 2001 and Australian Securities Exchange (ASX) Listing Rule 10.11 and for all other purposes, approval is given for the issue of to the equivalent of $18,000 in ordinary fully paid shares, in lieu of Directors’ Fees for the eighteen month period 1 January 2019 to 30 June

2

2020 to Ms K A Clark, Non-Executive Director of the Company, or her nominee(s) on the terms and conditions which are set out in the Explanatory Statement accompanying this Notice of Meeting.”

(The Company will disregard any votes cast on Resolution 6 by Ms K A Clark and by an associate of Ms Clark, as provided for in ASX Listing Rules 10.11 and 14.11. However the Company need not disregard any vote by any such persons on Resolution 6 if it is cast by any of them as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form, or it is cast by the person who is chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

7 – Issue of Shares to a Director in lieu of Directors’ Fees – Ms S Chau

To consider and, if thought fit, to pass the following resolution as an ordinary resolution :

“That, for the purposes of Section 208 of the Corporations Act 2001 and Australian Securities Exchange (ASX) Listing Rule 10.11 and for all other purposes, approval is given for the issue of up to the equivalent of $18,000 in ordinary fully paid shares, in lieu of Directors’ Fees for the eighteen month period 1 January 2019 to 30 June 2020 to Ms S Chau, Non-Executive Director of the Company’s wholly owned Subsidiary Company, Mount Burgess (Botswana) (Proprietary) Ltd, or her nominee(s) on terms and conditions which are set out in the Explanatory Statement accompanying this Notice of Meeting.

(The Company will disregard any votes cast on Resolution 7 by Ms S Chau and by an associate of Ms Chau, as provided for in ASX Listing Rules 10, 11 and 14.11. However the Company need not disregard any vote by any such person on Resolution 7 if it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form or it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

8 – Issue of Shares to a Director in lieu of Directors’ Fees – Ms J Forrester

To consider and, if thought fit, to pass the following resolution as an ordinary resolution :

“That, for the purposes of Section 208 of the Corporations Act 2001 and Australian Securities Exchange (ASX) Listing Rule 10.11 and for all other purposes, approval is given for the issue of up to the equivalent of $18,000 in ordinary fully paid shares, in lieu of Directors’ Fees for the eighteen month period 1 January 2019 to 30 June 2020 to Ms J Forrester, Non-Executive Director of the Company’s wholly owned Subsidiary Company, Mount Burgess (Botswana) (Proprietary) Ltd, or her nominee(s) on terms and conditions which are set out in the Explanatory Statement accompanying this Notice of Meeting.

(The Company will disregard any votes cast on Resolution 8 by Ms Forrester and by an associate of Ms Forrester, as provided for in ASX Listing Rules 10, 11 and 14.11. However the Company need not disregard any vote by any such person on Resolution 8 if it is cast by a person as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form or it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

9 - Issue of Shares to a Director in lieu of Directors’ Fees – Mr C Campbell-Hicks

To consider and, if thought fit, to pass the following as an ordinary resolution :

“That, for the purposes of Section 208 of the Corporations Act 2001 and Australian Securities Exchange (ASX) Listing Rule 10.11 and for all other purposes, approval is given for the issue of up to the equivalent of $18,000 in ordinary fully paid shares, in lieu of Directors’ Fees for the eighteen month period 1 January 2019 to 30 June 2020 to Mr C Campbell-Hicks, Non-Executive director of the Company or his nominees(s) on the terms and conditions which are set out in the Explanatory Statement accompanying this Notice of Meeting.”

(The Company will disregard any votes cast on Resolution 9 by any associates of Mr C Campbell-Hicks, as provided for in ASX Listing Rules 10.11 and 14.11. However the Company need not disregard any vote by any such persons on Resolution 9 if it is cast by any of them as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form, or it is cast by the person who is chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

10 - Issue of Shares to a Director in lieu of Directors’ Fees – Mr H Warries

To consider and, if thought fit, to pass the following as an ordinary resolution :

“That, for the purposes of Section 208 of the Corporations Act 2001 and Australian Securities Exchange (ASX) Listing Rule 10.11 and for all other purposes, given for the issue of up to the equivalent of $18,000 in ordinary

3

fully paid shares, in lieu of Directors’ Fees for the eighteen month period 1 January 2019 to 30 June 2020 to Mr H Warries, Non-Executive Director of the Company or his nominees(s) on the terms and conditions which are set out in the Explanatory Statement accompanying this Notice of Meeting.”

(The Company will disregard any votes cast on Resolution 10 by Mr H Warries and by an associate of Mr Warries, as provided for in ASX Listing Rules 10.11 and 14.11. However the Company need not disregard any vote by any such persons on Resolution 10 if it is cast by any of them as proxy for a person who is entitled to vote, in accordance with the directions on the proxy form, or it is cast by the person who is chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the proxy decides.)

11 – Approval of Issue of Placement Options

To consider and, if thought fit, pass the following as an ordinary resolution

That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, approval is given for the Company to issue 34,666,667 Options. The Options are exercisable at $0.015 at any time up until their expiry on 31 May 2023 on the terms and conditions set out in the Explanatory Statement.

(The Company will disregard any votes cast in favour of the Resolution by or on behalf of:

  • a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the Company).

However, this does not apply to a vote cast in favour of the Resolution by:

  • (a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or

  • (b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or

  • (c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way .)

12 – Approval of 10% Placement Facility – SPECIAL RESOLUTION

To consider and, if thought fit, to pass with or without amendment, as a special resolution the following:

"that, pursuant to and in accordance with Listing Rule 7.1A and for all other purposes, Shareholders approve the issue of Equity Securities up to 10% of the issued capital of the Company (at the time of the issue) calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 over a 12 month period on the terms and condition set out in the Explanatory Statement."

(The Company will disregard any votes cast in favour of this Resolution by or on behalf of:

  • a person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the Company), and any associates of those persons.

However, the Company will not disregard a vote if:

  • it is cast by a person as a proxy for a person who is entitled to vote, in accordance with the directions on the Proxy Form, or, it is cast by the person chairing the meeting as proxy for a person who is entitled to vote, in accordance with a direction on the Proxy Form to vote as the proxy decides.)

Electronic Annual Report

Shareholders are advised that the Company’s 2020 Annual Report is now available in pdf format to view/download at http://www.mountburgess.com

Explanatory Statement

The accompanying Explanatory Statement forms part of this Notice of General Meeting and should be read in conjunction with it.

4

Proxies

Please note that:

  • (a) a Shareholder entitled to attend and vote at the Meeting is entitled to appoint a proxy;

  • (b) a proxy need not be a member of the Company;

  • (c) a Shareholder may appoint a body corporate or an individual as its proxy;

  • (d) a body corporate appointed as a Shareholder’s proxy may appoint an individual as its representative to exercise any of the powers that the body may exercise as the Shareholder’s proxy; and

  • (e) Shareholders entitled to cast two or more votes may appoint two proxies and may specify the proportion of number of votes each proxy is appointed to exercise, but where the proportion or number is not specified, each proxy may exercise half of the votes.

The enclosed proxy form provides further details on appointing proxies and lodging proxy forms. If a shareholder appoints a body corporate as its proxy and the body corporate wishes to appoint an individual as its representative, a certificate of appointment of corporate representative should be completed and lodged in the manner specified below.

The Proxy Form (and any Power of Attorney under which it is signed) must be sent or delivered, or sent by facsimile to either the Company’s Registered Office (Fax No. 08 9355 1484 – 8/800 Albany Highway, East Victoria Park, Western Australia 6101, or the offices of Advanced Share Registry Services - 150 Stirling Highway, Nedlands, Western Australia 6009. Please note that all Proxy Forms must be received at either of the above addresses not later than 48 hours before the commencement of the meeting i.e. by 2.30 p.m. on 28 November 2020 WST. Any Proxy Form received after that time will not be valid for the scheduled meeting.

Entitlement to vote

The Board has determined that for the purpose of determining entitlements to attend and vote at the meeting, shares will be taken to be held by the persons who are the registered holders at 2.30 pm (WST) on 28 November 2020. Accordingly, share transfers registered after that time will be disregarded in determining entitlements to attend and vote at the meeting.

Corporate Representative

Any corporate Shareholder who has appointed a person to act as its corporate representative at the Annual General Meeting should provide that person with a certificate or letter executed in accordance with the Corporations Act authorising him or her to act as that company’s representative. The authority may be sent to the Company or its share registry in advance of the Annual General Meeting or handed in at the Annual General Meeting when registering as a corporate representative.

By Order of the Board of Directors

==> picture [161 x 32] intentionally omitted <==

Company Secretary

Mount Burgess Mining N.L 30 October 2020

5

EXPLANATORY STATEMENT

This Explanatory Statement has been prepared for the information of Shareholders in relation to the business to be conducted at the Company’s 2020 Annual General Meeting.

The purpose of this Explanatory Statement is to provide Shareholders with all information known to the Company which is material to a decision on how to vote on the resolutions in the accompanying Notice of Annual General Meeting. This Explanatory Statement is intended to be read in conjunction with the Notice of Meeting.

In accordance with the Company’s Constitution, the business of the Annual General Meeting will include receipt and consideration of the annual financial report of the Company for the financial year ended 30 June 2020 together with the declaration of the Directors, the Directors’ report, the remuneration report and the auditor’s report.

As a Shareholder you are entitled to submit written questions to the auditor prior to the Annual General Meeting provided that the question relates to:

  • The content of the auditor’s report; or

  • The conduct of the audit in relation to the financial report

All written questions must be sent to the Company and may not be sent directly to the auditor. The Company will then forward all questions to the auditor.

The auditor will be attending the Annual General Meeting and will be available to answer questions from Shareholders relevant to:

  • The conduct of the audit;

  • The preparation and content of the auditor’s report;

  • The accounting policies adopted by the Company in relation to the preparation of the financial statements; and

The independence of the auditor in relation to the conduct of the audit.

The auditor will also answer written questions submitted prior to the Annual General Meeting.

The Company does not provide a hard copy of the Company’s annual financial report unless specifically requested to do so. Shareholders may view the Company’s annual financial report on its website at www.mountburgess.com.

Under Resolution 1 the Company is seeking shareholders to vote on an advisory resolution that the Remuneration Report be adopted. Further detailed information is provided under Item 1 of this Explanatory Statement.

Under Resolution 2 the Company is seeking Shareholder ratification of a previous issue of securities made under Listing Rule 7.1. Further detailed information as required under LR 7.5 is provided under Item 2 of this Explanatory Statement.

Under Resolution 3 the Company is seeking Shareholder ratification of a previous issue of securities made under Listing Rule 7.1. Further detailed information as required under LR 7.5 is provided under Item 3 of this Explanatory Statement.

Under Resolution 4 the Company is seeking Shareholder ratification of a previous issue of securities made under Listing Rule 7.1. Further detailed information as required under LR 7.5 is provided under Item 4 of this Explanatory Statement.

Under Resolution 5 the Company is seeking shareholder approval for the re-election of a Director. More details are provided under Item 5 of this Explanatory Statement.

Under Resolutions 6, 7, 8, 9 and 10 the Company is proposing to issue shares in lieu of Directors’ fees to current nonExecutive Directors of the Company and its wholly owned subsidiary Company, Mount Burgess (Botswana) (Proprietary) Ltd, namely Ms Clark, Ms Chau, Ms Forrester and Messrs Campbell-Hicks and Warries and is seeking approval from members as required by Section 208 of the Corporations Act and Listing Rule 10.11 and Exception 4 of Listing Rule 10.12. Further detailed information is provided in Item 6 of this Explanatory Statement.

Under Resolution 11 the Company is seeking Shareholder approval for the issue of 34,666,667 ‘free attaching’ Options. Further detailed information is provided in Item 7 of this Explanatory Statement.

Under Resolution 12 the Company is seeking shareholder approval for a 10% Placement Facility in terms of ASX Listing Rule 7.1A and further details are given under Item 8 of this Explanatory Statement.

.

6

1. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT

1.1 General

The remuneration report of the Company for the financial year ended 30 June 2020 is set out in MTB’s 2020 Annual Report which is available on MTB’s website: www.mountburgess.com.

The remuneration report sets out the Company’s remuneration arrangements for Directors. The Chairman of the meeting will allow a reasonable opportunity for shareholders to ask questions about, or make comments on, the remuneration report at the meeting. In addition, shareholders will be asked to vote on the remuneration report. The resolution is advisory only and does not bind the Company or its Directors. The Board will consider the outcome of the vote and comments made by shareholders on the remuneration report at the meeting when reviewing the Company’s remuneration policies. Under the Corporations Act 2001, if 25% or more of votes that are cast are voted against the adoption of the remuneration report at two consecutive AGMs, shareholders will be required to vote at the second of those AGMs on a resolution (a “spill resolution”) that another meeting be held within 90 days at which all of the Company’s Directors (other than the Managing Director) must go up for re-election.

The Board unanimously recommends that shareholders vote in favour of adopting the Remuneration Report and encourages all shareholders to cast their votes on Resolution 1.

1.2 Voting Restrictions where Proxy is Chairman or Key Management Personnel

In accordance with section 250R (4) of the Act, no member of the key management personnel of the Company or a closely related party of such a member may vote on Resolution 1.

However, in accordance with the Act, a person described above may vote on Resolution 1 if:

• It is cast by such person as proxy for a person who is permitted to vote, in accordance with the direction specified on the proxy form how to vote; or

• It is cast by the Chairman as proxy for a person who is permitted to vote, in accordance with an express direction specified on the proxy form to vote as the proxy decides.

Chairman appointed as proxy:

If the Chairman is appointed as a proxy for a person who is permitted to vote on this Resolution 1, the Chairman will vote any proxies which do not indicate on their proxy form the way the Chairman must vote, in favour of Resolution 1.

1.3 Definitions

Key Management Personnel has the same meaning as in the accounting standards and broadly includes those persons having authority and responsibility for planning, directing and controlling the activities of the Company, directly or indirectly, including any director (whether executive or otherwise) of the Company.

Closely Related Party of a member of the Key Management Personnel means:

(a) a spouse or child of the member;

(b) a child of the member’s spouse;

  • (c) a dependent of the member or the member’s spouse;

  • (d) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;

(e) a company the member controls; or

  • (f) a person prescribed by the Corporations Regulations 2001 (Cth ).

Remuneration Report means the remuneration report set out in the Director’s report section of the Company’s annual financial report for the year ended 30 June 2020.

2. RESOLUTION 2 - RATIFICATION OF A PREVIOUS ISSUE OF SECURITIES UNDER LISTING RULE 7.1 TO SOPHISTICATED AND PROFESSIONAL INVESTORS IN NOVEMBER 2019

ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12 month period to that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period.

ASX Listing Rule 7.4 sets out an exception to ASX Listing Rule 7.1. It provides that where a company in general meeting ratifies the previous issue of securities made pursuant to ASX Listing Rule 7.1 (and provided that the previous issue did

7

not breach ASX Listing Rule 7.1) those securities will be deemed to have been made with Shareholder approval for the purpose of ASX Listing Rule 7.1. Shareholder approval can be obtained either before or after the equity securities are issued.

Resolution 2 is an ordinary resolution under which the Company seeks approval from Shareholders for and ratification of 12,000,000 ordinary fully paid shares as detailed below to Sophisticated and Professional Investors. The Company confirms that the issue did not breach the Company’s 15% placement capacity under ASX Listing Rule 7.1 at that time. The following information is provided in accordance with ASX Listing Rule 7.5.

No. of Securities Issued: 12,000,000 ordinary shares. Issue Price: 0.25 of one cent per share Issue Date: 21 November 2019 Use of Proceeds: The Company has applied funds raised in the above placement towards mineralogical and metallurgical test work conducted for resource development of its Kihabe Zinc/Lead/Silver/Vanadium and Germanium project in Botswana, together with corporate administration costs. Terms of Securities: All shares were issued as fully paid ordinary shares ranking equally with existing shares. Quotation on the ASX was sought and obtained. Allottee: The shares were issued to Sophisticated and Professional Investors as follows: Graham Forward Pty Ltd (GJ Family A/c) 5,000,000 Peloton Pty Ltd 5,000,000 Cen Pty Ltd 2,000,000 None of the allottees were Related Parties. Recommendation: The Board believes that the ratification of these issues is beneficial for the Company. The Board unanimously recommends Shareholders vote in favour of Resolution 2, as it allows the Company to ratify the above issues of Shares and retain the flexibility to issue the maximum number of equity securities permitted under Listing Rule 7.1 without Shareholder approval.

If Resolution 2 is not passed the November 2019 placement share issue will be excluded in calculating the Company’s15% capacity under Listing Rule 7.1, thereby decreasing the number of equity securities it can issue under Listing Rule 7.1 without shareholder approval.

3. RESOLUTION 3 - RATIFICATION OF A PREVIOUS ISSUE OF SECURITIES UNDER LISTING RULE 7.1 TO SOPHISTICATED AND PROFESSIONAL INVESTORS IN MARCH 2020

ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12 month period to that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period.

ASX Listing Rule 7.4 sets out an exception to ASX Listing Rule 7.1. It provides that where a company in general meeting ratifies the previous issue of securities made pursuant to ASX Listing Rule 7.1 (and provided that the previous issue did not breach ASX Listing Rule 7.1) those securities will be deemed to have been made with Shareholder approval for the purpose of ASX Listing Rule 7.1. Shareholder approval can be obtained either before or after the equity securities are issued.

Resolution 3 is an ordinary resolution under which the Company seeks approval from Shareholders for and ratification of 35,333,333 ordinary fully paid shares as detailed below to Sophisticated and Professional Investors. The Company confirms that the issue did not breach the Company’s 15% placement capacity under ASX Listing Rule 7.1 at that time. The following information is provided in accordance with ASX Listing Rule 7.5.

No. of Securities Issued:

35,333,333 ordinary shares.

Issue Price:

0.15 of one cent per share

8

13 March 2020

Issue Date:

Use of Proceeds:

The Company has applied funds raised in the above placement towards mineralogical and metallurgical test work conducted for resource development of its Kihabe Zinc/Lead/Silver/Vanadium and Germanium project in Botswana together with corporate administration costs.

Terms of Securities:

All shares were issued as fully paid ordinary shares ranking equally with existing shares. Quotation on the ASX was sought and obtained.

Allottee:

The shares were issued to Sophisticated and Professional Investors as follows:

Mr Michael Damian Murphy 2,000,000 Armuk Pty Ltd 20,000,000 JERD Pty Ltd 10,000,000 Cen Pty Ltd 3,333,333

None of the allottees were Related Parties.

Recommendation: The Board believes that the ratification of these issues is beneficial for the Company. The Board unanimously recommends Shareholders vote in favour of Resolution 3, as it allows the Company to ratify the above issues of Shares and retain the flexibility to issue the maximum number of equity securities permitted under Listing Rule 7.1 without Shareholder approval.

If Resolution 3 is not passed the March 2020 placement share issue will be excluded in calculating the Company’s15% capacity under Listing Rule 7.1, thereby decreasing the number of equity securities it can issue under Listing Rule 7.1 without shareholder approval.

4. RESOLUTION 4 - RATIFICATION OF A PREVIOUS ISSUE OF SECURITIES UNDER LISTING RULE 7.1 TO SOPHISTICATED AND PROFESSIONAL INVESTORS IN JULY 2020

ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12 month period to that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period.

ASX Listing Rule 7.4 sets out an exception to ASX Listing Rule 7.1. It provides that where a company in general meeting ratifies the previous issue of securities made pursuant to ASX Listing Rule 7.1 (and provided that the previous issue did not breach ASX Listing Rule 7.1) those securities will be deemed to have been made with Shareholder approval for the purpose of ASX Listing Rule 7.1. Shareholder approval can be obtained either before or after the equity securities are issued.

Resolution 4 is an ordinary resolution under which the Company seeks approval from Shareholders for and ratification of 30,686,075 ordinary fully paid shares as detailed below to Sophisticated and Professional Investors. The Company confirms that the issue did not breach the Company’s 15% placement capacity under ASX Listing Rule 7.1 at that time. The following information is provided in accordance with ASX Listing Rule 7.5.

No. of Securities Issued:

No. of Securities Issued: 30,686,075 ordinary shares. Issue Price: 0.15 of one cent per share Issue Date: 8 July 2020 Use of Proceeds: The Company has applied funds raised in the above placement towards mineralogical and metallurgical test work conducted for resource development of its Kihabe Zinc/Lead/Silver/Vanadium and Germanium project in Botswana, together with corporate administration costs.

Terms of Securities: All shares were issued as fully paid ordinary shares ranking equally with existing shares. Quotation on the ASX was sought and obtained.

Allottee:

The shares were issued to Sophisticated and Professional Investors as follows:

9

Mrs Luye Li 12,700,000 Mr Geoffrey Allen Bailey 10,000,000 Benken Capital Group Pty Ltd 1,400,000 Mr Ben Michael Faulkner 4,586,075 Cen Pty Ltd 2,000,000

None of the allottees were Related Parties.

Recommendation:

The Board believes that the ratification of these issues is beneficial for the Company. The Board unanimously recommends Shareholders vote in favour of Resolution 4, as it allows the Company to ratify the above issues of Shares and retain the flexibility to issue the maximum number of equity securities permitted under Listing Rule 7.1 without Shareholder approval.

If Resolution 4 is not passed the July 2020 placement share issue will be excluded in calculating the Company’s15% capacity under Listing Rule 7.1, thereby decreasing the number of equity securities it can issue under Listing Rule 7.1 without shareholder approval.

5. RESOLUTION 5 – RE-ELECTION OF DIRECTOR – CHRIS CAMPBELL-HICKS

In accordance with Listing Rule 14.4 and the Company’s Constitution, at every Annual General Meeting, one third of the Directors for the time being must retire from office by rotation and are eligible for re-election. The Directors to retire are to be those who have been in office for 3 years since their appointment or last reappointment or, if the Directors have been in office for an equal length of time, by agreement. Mr Campbell-Hicks retires by rotation at this meeting and, being eligible, offers himself for re-election.

A profile of Mr Campbell-Hicks is outlined below:

Chris Campbell-Hicks Non Executive Director

Mr Campbell-Hicks 73 has more than forty year’s experience in the mineral processing industry in base metals, precious metals, alumina and iron ore. He has spent extensive time developing projects in Africa, South America, PNG, Fiji, Indonesia, Turkey, Kazakhstan and several other countries as well as five years with Barrick Gold as Manager Metallurgy, based in Moscow, Siberia and Canada. In 2005,

Chris was founding Director of Mineral Process Control which successfully developed and commercialised the original cyanide leach accelerator LeachWELL. As senior design engineer with Western Minerals Technology he was a key member of the team that successfully designed and constructed the copper, nickel, cobalt low temperature Activox acid leach SX-EW demonstration plant that won the Australian national award for engineering excellence in 2004.

Chris is currently employed as a Principal Process Engineer with Sedgman Engineering while also assuming duties in technical innovation and business development.

The Board (other than Mr Campbell-Hicks) recommend that Shareholders support the resolution re-electing Mr CampbellHicks as a director of the Company especially as his metallurgical skills are essential for the development of the Company’s Kihabe-Nxuu Polymetallic Project.

If Resolution 5 is not approved the Company will have to seek to appoint an alternative metallurgist of equal experience necessary for the future development of its polymetallic Zn/Pb/Ag/Ge/V Kihabe-Nxuu Project.

6. RESOLUTIONS 6, 7, 8, 9 and 10 - ISSUE OF SHARES TO DIRECTORS IN LIEU OF DIRECTORS’ FEES

6.1 General

The Company has agreed, subject to obtaining Shareholder approval, to issue a total of $90,000 worth of fully paid ordinary shares in the capital of the Company ( Shares ) to the related parties as follows:

Resolution 6 Ms K A Clark $18,000
Resolution 7 Ms S Chau $18,000
Resolution 8 Ms J Forrester $18,000
Resolution 9 Mr C Campbell-Hicks $18,000
Resolution 10 Mr H Warries $18,000

on the terms and conditions set out below.

10

For a public company, or an entity that the public company controls, to give a financial benefit to a related party of the public company, the public company or entity must:

  • (a) obtain the approval of the public company’s members in the manner set out in Sections 217 to 227 of the Corporations Act; and

  • (b) give the benefit within 15 months following such approval, unless the giving of the financial benefit falls within an exception set out in Sections 210 to 216 of the Corporations Act.

In addition, ASX Listing Rule 10.11 also requires shareholder approval to be obtained where an entity issues, or agrees to issue, securities to a related party, or a person whose relationship with the entity or a related party is, in ASX’s opinion, such that approval should be obtained unless an exception in ASX Listing Rule 10.12 applies. Listing Rule 10.13.3 requires the shares to be issued within one month after the date of approval by shareholders in general meeting.

The issue of the Shares to the Related Parties requires the Company to obtain Shareholder approval because the grant of Director Shares constitutes giving a financial benefit and as Directors, Ms Clark, Ms Chau, Ms Forrester and Messrs Campbell-Hicks and Warries are related parties of the Company. It is the view of the Directors that the exceptions set out in Sections 210 to 216 of the Corporations Act and ASX Listing Rule 10.12 may not apply in the current circumstances. Accordingly, Shareholder approval is sought for the grant of Shares to the Related Parties.

4.2 Shareholder Approval (Chapter 2E of the Corporations Act and Listing Rule 10.11)

Pursuant to and in accordance with the requirements of Sections 217 to 227 of the Corporations Act and ASX Listing Rule 10.13, the following information is provided in relation to the proposed grant of Shares:

  • (a) the related parties are Ms Clark, Ms Chau, Ms Forrester and Messrs Campbell-Hicks and Warries and they are related parties by virtue of being non-executive Directors;

  • (b) the maximum number of Shares (being the nature of the financial benefit being provided) to be issued under this approval to the Related Parties is:

  • (i) $18,000 worth of fully paid ordinary shares to Ms K Clark

  • (ii) $18,000 worth of fully paid ordinary shares to Ms S Chau

  • (iii) $18,000 worth of fully paid shares to Ms J Forrester

  • (iv) $18,000 worth of fully paid shares to Mr C Campbell-Hicks

  • (v) $18,000 worth of fully paid shares to Mr H Warries

The fully paid shares would be issued at the volume weighted average price (“VWAP”) of the shares in the five ASX trading days prior to issue after approval by shareholders.

As an example, between 1 September and 1 October 2020 (date of preparation of this Notice of Meeting) Mount Burgess shares traded between 0.7 of 1 cent and 1.2 cents and at the date of preparation of this Notice was $0.007. Therefore if the Mount Burgess share price (VWAP) was 0.7 of a cent per share then 2,571,428 shares would be issued to each of Ms Clark, Ms Chau, Ms Forrester and Messrs Campbell-Hicks and Warries. If the Mount Burgess share price (VWAP) was the higher figure of 1.2 cents then 1,500,000 shares would be issued to each of Ms Clark, Ms Chau, Ms Forrester and Messrs Campbell-Hicks and Warries.

  • (c) the Shares will be issued to the Related Parties no later than one month after the date of the Annual General Meeting (or such later date as permitted by any ASX waiver or modification of the ASX Listing Rules) and it is anticipated the Shares will be issued on one date;

  • (d) the Shares are being issued to the non-executive Directors in lieu of directors fees for the eighteen months from 1 January 2019 to 30 June 2020. As such the Shares will be granted for nil cash consideration, and no funds will be raised;

  • (e) the shares issued will be fully paid ordinary shares in the capital of the Company and on the same terms as the Company’s existing shares;

  • (f) The proposed grantees’ current shareholdings in the Company including any associates are listed below.

Fully Paid Ordinary Shares Ms K A Clark 7,577,532 Ms S Chau 7,537,373 Ms J Forrester & Associates 65,063,219 Mr C Campbell-Hicks 8,114,676 Mr H Warries 7,151,818

the non-executive directors’ remuneration from the Company to the Related Parties is shown below:

11

(g)

Related Party Approved
Fees/Salary from
1 January 2019 to
30 June 2020
Paid (cash)
18 months from
1 January 2019 to
30 June 2020
($)
Approval
sought in
shares
($)
Ms K Clark 18,000.00 NIL 18,000.00
Ms S Chau & Associates 114,758.30 96,758.30 18,000.00
Ms J Forrester & Associates 18,000.00 NIL 18,000.00
Mr C Campbell-Hicks & Associates 18,000.00 NIL 18,000.00
Mr H Warries & Associates 18,000.00 NIL 18,000.00

(h) The trading history of the shares on ASX in the 12 months before the preparation of this Notice of Annual General Meeting is set out below:

of the shares on ASX in the
elow:
12 months before the preparation of this
Price Date
Highest 2.8 cents on 19 August 2020
Lowest 0.1 of a cent on 4 August 2020
Last 0.7 of a cent on 30 September 2020
  • (i) As at 1 October 2020, the date of preparation of this Notice of Meeting and Explanatory Statement, the Company’s issued share capital stands at 650,148,799 shares. If approval is given by shareholders for the issue of shares to be granted in accordance with Resolutions 6-10 then the following would apply.

Assuming VWAP share prices in (h) above

At 2.8 cents

  • the Company’s issued shares would increase by 3,214,285

  • existing shareholders’ holdings would be diluted by 0.49%

  • the individual directors and their associates would hold the following shares:


the individual directors and their associa
tes would hold t he following share
**Director ** Shares Percentage of
**Issued Capital **
K A Clark 8,220,389 1.26%
S Chau & Associates 8,180,230 1.25%
J Forrester & Associates 65,706,076 10.06%
C Campbell-Hicks & Associates 8,757,533 1.34%
H Warries &Associates 7,794,675 1.19%

At 0.1 of a cent

  • the Company’s issued shares would increase by 90,000,000

  • existing shareholders’ holdings would be diluted by 12.16%

  • the individual directors and their associates would hold the following shares:

**Director ** Shares Percentage of
**Issued Capital **
K A Clark 25,577,512 3.46%
S Chau &Associates 25,537,373 3.45%
J Forrester & Associates 83,063,219 11.22%
C Campbell-Hicks & Associates 26,114,676 3,53%
H Warries &Associates 25,151,818 3.40%

At 0.7 of a cent

  • the Company’s issued shares would increase by 12,857,143

  • existing shareholders’ holdings would be diluted by 1.94%

  • the individual directors and their associates would hold the following shares:

12

**Director ** Shares Percentage of
**Issued Capital **
K A Clark 10,148,960 1.53%
S Chau &Associates 10,108,801 1.52%
J Forrester & Associates 67,634,647 10.20%
C Campbell-Hicks & Associates 10,686,104 1.61%
H Warries &Associates 9,723,246 1.47%

Any further issue of shares by the Company after the release of this notice but prior to the holding of the Company’s Annual General Meeting will affect the above percentages of issued share capital held by the directors of the Company.

As at 1 October 2020 the date of preparation of this Notice of Meeting and Explanatory Statement, the Company had no availability to issue shares either under Listing Rule 7.1 or Listing Rule 7.1A

  • (j) the main purpose of the issue of the Shares to the Related Parties is to provide cost effective consideration to the Related Parties for their contribution to the Company in their respective roles as Directors. The Board does not consider that there are any significant opportunity costs to the Company or benefits foregone by the Company in issuing the Shares upon the terms proposed;

  • (k) the Board acknowledges the issue of Shares to the Related Parties is contrary to Recommendation 8.2 of the ASX Corporate Governance Principles and Recommendations. However, the Board considers the grant of Shares to the Related Parties is reasonable in the circumstances, given the necessity to maintain the Company’s cash reserves;

  • (l) If any of Resolutions 6-10 are not approved by shareholders the Company will not necessarily be in a financial position to afford the payment of directors’ fees in cash.

  • (m) The Company will not be subject to Fringe Benefits Tax or be liable for additional taxes in the event Resolutions 6- 10 are approved and the relevant shares issued.

  • (n) Ms Clark declines to make a recommendation to Shareholders in relation to Resolution 6 due to her material personal interest in the outcome of the Resolution. The other Directors, who do not have a material interest in the outcome of Resolution 6, recommend that Shareholders vote in favour of Resolution 6. The Board, excluding Ms Clark, is not aware of any other information that would be reasonably required by Shareholders to allow them to make a decision whether it is in the best interests of the Company to pass the Resolution;

  • (o) Ms Chau declines to make a recommendation to Shareholders in relation to Resolution 7 due to her material personal interest in the outcome of the Resolution. The other Directors, who do not have a material interest in the outcome of Resolution 6, recommend that Shareholders vote in favour of Resolution 7. The Board, excluding Ms Chau, is not aware of any other information that would be reasonably required by Shareholders to allow them to make a decision whether it is in the best interests of the Company to pass the Resolution;

  • (p) Ms Forrester declines to make a recommendation to Shareholders in relation to Resolution 8 due to her material personal interest in the outcome of the Resolution. The other Directors, who do not have a material interest in the outcome of Resolution 8 recommend that Shareholders vote in favour of Resolution 8. The Board, excluding Ms Forrester , is not aware of any other information that would be reasonably required by Shareholders to allow them to make a decision whether it is in the best interests of the Company to pass the Resolution; and

  • (q) Mr Campbell-Hicks declines to make a recommendation to Shareholders in relation to Resolution 9 due to his material personal interest in the outcome of the Resolution. The other Directors, who do not have a material interest in the outcome of Resolution 9 recommend that Shareholders vote in favour of Resolution 9. The Board, excluding Mr Campbell-Hicks, is not aware of any other information that would be reasonably required by Shareholders to allow them to make a decision whether it is in the best interests of the Company to pass the Resolution.

  • (r) Mr Warries declines to make a recommendation to Shareholders in relation to Resolution 10 due to his material personal interest in the outcome of the Resolution. The other Directors, who do not have a material interest in the outcome of Resolution 10 recommend that Shareholders vote in favour of Resolution 10. The Board, excluding Mr Warries, is not aware of any other information that would be reasonably required by Shareholders to allow them to make a decision whether it is in the best interests of the Company to pass the Resolution

7. RESOLUTION 11 - AUTHORITY TO ISSUE PLACEMENT OPTIONS

7.1 General

On 18 September 2020 the Company announced a capital raising made through a placement issue of 52,000,000 fully paid ordinary shares under ASX LR 7.1A which included 34,666,667 free attaching options, based on 2 options for every

13

3 shares subscribed for. As noted in the Company's announcement to ASX on 18 September 2020, the Company has agreed, subject to Shareholder approval, to issue 34,666,667 Options (Placement Options) to the September 2020 Placement Participants (and/or their nominees) as free attaching Options on the basis of 2 Placement Options for every 3 Placement Shares subscribed for. Accordingly no funds will be raised from the issue of the Placement Options.

The Placement Options will each be exercisable at $0.015 on or before 31 May 2023. Further terms and conditions of the Placement Options are set out in Schedule 1.

Resolution 11, which is an ordinary resolution, seeks Shareholder approval pursuant to ASX Listing Rule 7.1 for the issue of those Placement Options and for the purposes of Listing Rule 7.1.

If Resolution 11 is passed the Company will be able to proceed to issue the 34,666,667 Placement Options as announced on 18 September 2020. Also, the Placement Options will be excluded from the 15% calculation of the number of equity securities that the company can issue without shareholder approval under Listing Rule 7.1

If Resolution 11 is not passed the Company will need to issue the 34,666,667 Placement Options out of its 15% placement capacity under Listing Rule 7.1 provided that Resolutions 2, 3 and 4 are passed.

7.2 Technical information required by ASX Listing Rule 7.1

Pursuant to and in accordance with ASX Listing Rule 7.3, the following information is provided in relation to the ratification of the Shares:

(a) the Placement Options will be issued to the participants of the September 2020 Placement , and/or their nominees, who are not related parties of the Company.

(b) 34,666,667 Placement Options will be issued as a new class of securities exercisable at $0.015 on or before 31 May 2023, on the terms and conditions set out in Schedule 1 and subject to ASX quotation requirements

(c) the Placement Options will be issued on or about 3 December 2020 or otherwise not later than 3 months after the date of the Meeting;

(d) The Company undertakes that if required, it will give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with ASIC a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Placement Options does not require disclosure to investors; and will apply for official quotation on ASX of Shares issued pursuant to the exercise of the Options.

(e) the issue price is nil per Placement Option as they are free-attaching to the Shares issued under the September 2020 Placement ;

(f) the purpose of the issue of the 52,000,000 shares to which the Placement Options are attached, subject to approval, was to raise funds for the development of the Company’s Kihabe-Nxuu Polymetallic Project;

(g) no funds are being raised from the issue of the Placement Options as they are free-attaching to the September 2020 Placement Shares

(h) the Placement Options are not being issued under an agreement;

(i) the Placement Options are not being issued under or to fund a reverse takeover;

(j) shares issued on exercise of the Placement Options will be fully paid ordinary shares in the capital of the Company ranking equally in all respects with the Company’s existing shares on issue

(k) it is expected that all the Placement Options will be issued on one date

(l) a voting exclusion statement is set out in the Notice. The Directors of the Company believe Resolution 11 is in the best interest of the Company and its Shareholders and unanimously recommend that the Shareholders vote in favour of this Resolution.

8. RESOLUTION 12 – APPROVAL OF 10% PLACEMENT FACILITY (SPECIAL RESOLUTION)

8.1 General

Listing Rule 7.1A enables eligible entities to issue Equity Securities up to 10% of its issued share capital through placements over a 12 month period after approval at the Annual General Meeting (10% Placement Facility). The 10% Placement Facility is in addition to the Company’s 15% placement capacity under Listing Rule 7.1.

An “Eligible Entity” for the purposes of Listing Rule 7.1A is an entity which, as at the date of the relevant special resolution passed for the purposes of rule 7.1A, (excluding restricted securities and securities quoted on a deferred settlement basis) is not included in the S&P/ASX 300 Index and has a market capitalisation of $300 million or less. As at the date of preparation of this Notice, 1 October 2020, the Company’s market capitalisation for this purpose is $4,551,042 and the Company expects to be an Eligible Entity at the time of the Meeting.

The Company is now seeking shareholder approval to have the ability, by way of a special resolution, to issue Equity Securities under the 10% Placement Facility.

14

The exact number of Equity Securities to be issued under the 10% Placement Facility will be determined in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer to 8.2 (c) below).

The Company will apply funds raised to administration costs as well as to exploration and resource development activities on its Kihabe Zn/Pb/Ag/V/Ge Project in Western Ngamiland, Botswana.

If Resolution 12 is passed, the Directors will be able to issue Equity Securities in the Company for up to 10% of the Company’s Securities on issue during the period up to 12 months after the Meeting, calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2.

If Resolution 12 is not passed, the Directors will be unable to issue Equity Securities under the Company's 10% Additional Placement Capacity and the Company will be unable to raise funds using the Company's 10% Additional Placement Capacity.

.

8.2 Description of Listing Rule 7.1A

(a) Shareholder approval

The ability to issue Equity Securities under the 10% Placement Facility is subject to shareholder approval by way of a special resolution at an Annual General Meeting.

(b) Equity Securities

Any Equity Securities issued under the 10% Placement Facility must be in the same class as an existing quoted class of Equity Securities of the Company.

The Company currently has only one class of quoted Equity Securities on issue being the Ordinary Shares in the Company.

(c) Formula for calculating 10% Placement Facility

Listing Rule 7.1A.2 provides that eligible entities which have obtained shareholder approval at an Annual General Meeting may issue or agree to issue, during the 12 month period after the date of the Annual General Meeting, a number of Equity Securities calculated in accordance with the following formula:

(A x D) – E

A represents the number of shares on issue 12 months before the date of issue or agreement:

  • (A) plus the number of fully paid shares issued in the 12 months under an exception in Listing Rule 7.2;

  • (B) plus the number of partly paid shares that became fully paid in the 12 months;

  • (C) plus the number of fully paid shares issued in the 12 months with approval of holders of shares under Listing Rule 7.1 and 7.4. This does not include an issue of fully paid shares under the entity's 15% placement capacity without shareholder approval;

  • (D) less the number of fully paid shares cancelled in the 12 months.

Note that A has the same meaning in Listing Rule 7.1 when calculating an entity's 15% placement capacity .

D is 10%

E is the number of Equity Securities issued or agreed to be issued under Listing Rule 7.1A.2 in the 12 months before the date of the issue or agreement to issue that are not issued with the approval of shareholders under Listing Rule 7.1 or 7.4.

(d) Listing Rule 7.1 and Listing Rule 7.1A

The ability of an entity to issue Equity Securities under Listing Rule 7.1A is in addition to the entity's 15% placement capacity under Listing Rule 7.1.

At 1 October 2020, the date of preparation of this Notice, the Company has on issue 650,148,799 Equity Securities. It therefore has a capacity to issue:

  • (i) 97,522,320 Equity Securities under Listing Rule 7.1 subject to approval being granted by shareholders under Resolutions 2, 3 and 4 of this Annual General Meeting of the Company and;

15

  • (ii) 65,014,880 Equity Securities under Listing Rule 7.1A subject to approval being granted by shareholders under Resolutions 2, 3 and 4 of this Annual General Meeting of the Company.

The actual number of Equity Securities that the Company will have capacity to issue under Listing Rule 7.1A will be calculated at the date of issue of the Equity Securities in accordance with the formula prescribed in Listing Rule 7.1A.2 (refer 8.2(c) above).

(e) 10% Placement Period

Shareholder approval of the 10% Placement Facility under Listing Rule 7.1A is valid from the date of the Annual General Meeting at which the approval is obtained and expires on the earlier to occur of:

  • (i) the date that is 12 months after the date of the Annual General Meeting at which the approval is obtained; or

(ii) the date of the approval by shareholders of a transaction under Listing Rules 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking), or such longer period if allowed by ASX.

8.3 Listing Rule 7.1A

The effect of Resolution 12 will be to allow the Directors to issue the Equity Securities under Listing Rule 7.1A during the 10% Placement Period without using the Company’s 15% placement capacity under Listing Rule 7.1.

Resolution 12 is a special resolution and therefore requires approval of 75% of the votes cast by Shareholders present and eligible to vote (in person, by proxy, by attorney or, in the case of a corporate Shareholder, by a corporate representative).

8.4 Specific information required by Listing Rule 7.3A

Pursuant to and in accordance with Listing Rule 7.3A, information is provided in relation to the approval of the 10% Placement Facility as follows:

(a) The Equity Securities will be issued at an issue price of not less than 75% of the VWAP for the Company's Equity Securities over the 15 Trading Days on which trades in that class were recorded immediately before:

  • (i) the date on which the price at which the Equity Securities are to be issued is agreed; or

  • (ii) if the Equity Securities are not issued within 5 Trading Days of the date in paragraph (i) above, the date on which the Equity Securities are issued.

(b) If Resolution 12 is approved by shareholders and the Company issues Equity Securities under the 10% Placement Facility, the existing shareholders’ voting power in the Company will be diluted as shown in Table 1 below. There is a risk that:

  • (i) the market price of the Company’s Equity Securities may be significantly lower on the date of the issue of the Equity Securities than on the date of the Meeting and

  • (ii) the Equity Securities may be issued at a price that is at a discount to the market price for the Company’s Equity Securities on the issue date or the Equity Securities are issued as part of consideration for the acquisition of a new asset, which may have an effect on the amount of funds raised by the issue of the Equity Securities.

Table 1 shows the risk of economic and voting the dilution of existing Shareholders on the basis of the market price of the Shares as at the preparation of this Notice of Annual General Meeting (1 October 2020) and the number of ordinary securities for variable "A" calculated in accordance with the formula in Listing Rule 7.1A(2) as at the date of this Notice.

Table 1 also shows:

  • (i) Two examples where variable “A” has increased, by 50% and 100%. Variable “A” is based on the number of ordinary securities the Company has on issue. The number of ordinary securities on issue may increase as a result of issues of ordinary securities that do not require Shareholder approval (for example, a pro rata entitlements issue or scrip issued under a takeover offer) or future specific placements under Listing Rule 7.1 that are approved at a future Shareholders’ meeting; and

  • (ii) Two examples showing where the issue price of ordinary securities has decreased by 50% and increased by 100% as against the current market price.

16

Table 1

Table 1
Variable
“A”
in
Listing
Rule
7.1A.2
**Dilution **
$0.0035
50% decrease in
issue price
$0.007
issue price
$0.014
100% increase
in issue price
650,148,799
Current Variable
A
10%VotingDilution 65,014,880 shares 65,014,880 shares 65,014,880 shares
FundsRaised $227,552 $455,104 $910,208
975,223,198
50% increase in
Current Variable
A
10% Voting Dilution 97,522,320 shares 97,522,320 shares 97,522,320 shares
Funds Raised $341,328 $661,656 $1,323,312
1,300,297,598
100% increase in
Current Variable
A
10% Voting Dilution 130,029,759 shares 130,029,759shares 130,029,759 shares
Funds Raised $455,104 $910,208 $1,820,417

The table has been prepared on the following assumptions:

  • (i) The Company issues the maximum number of Equity Securities available under the 10% Placement Facility.

  • (ii) No Listed Options (including any Listed Options issued under the 10% Placement Facility) are exercised into Shares before the date of the issue of the Equity Securities;

  • (iii) The 10% voting dilution reflects the aggregate percentage dilution against the issued share capital at the time of issue. This is why the voting dilution is shown in each example as 10%.

  • (iv) The table does not show an example of dilution that may be caused to a particular Shareholder by reason of placements under the 10% Placement Facility, based on that Shareholder’s holding at the date of the Meeting.

  • (v) The table shows only the effect of issues of Equity Securities under Listing Rule 7.1A, not under the 15% placement capacity under Listing Rule 7.1.

  • (vi) The issue of Equity Securities under the 10% Placement Facility consists only of Shares. If the issue of Equity Securities includes Listed Options, it is assumed that those Listed Options are exercised into Shares for the purpose of calculating the voting dilution effect on existing Shareholders.

  • (vii) The issue price is $0.007, being the closing price of the Shares on ASX as of 1 October 2020, the date of preparation of this notice.

(c) The Company will only issue and allot the Equity Securities during the 10% Placement Period. The approval under Resolution 12 for the issue of the Equity Securities will cease to be valid in the event that Shareholders approve a transaction under Listing Rule 11.1.2 (a significant change to the nature or scale of activities or Listing Rule 11.2 (disposal of main undertaking).

(d) The Company may seek to issue the Equity Securities for the following purposes:

  • (i) non-cash consideration for the acquisition of new resources assets and investments. In such circumstances the Company will provide a valuation of the non-cash consideration as required by Listing Rule 7.1A.3; or

  • (ii) cash consideration. In such circumstances, the Company intends to use the funds raised towards the exploration and resource development activities at its existing project and/or for acquisition of new assets or investments (including expenses associated with such acquisition) and general working capital.

The Company will comply with the disclosure obligations under Listing Rules 7.1A(4) and 3.10.5A upon issue of any Equity Securities.

The Company’s allocation policy is dependent on the prevailing market conditions at the time of any proposed issue pursuant to the 10% Placement Facility. The identity of the allottees of Equity Securities will be determined on a case-bycase basis having regard to the factors including but not limited to the following:

  • (i) the methods of raising funds that are available to the Company, including but not limited to, a rights issue or other issue in which existing security holders can participate;

17

  • (ii) the effect of the issue of the Equity Securities on the control of the Company;

  • (iii) the financial situation and solvency of the Company; and

  • (iv) advice from corporate, financial and broking advisers (if applicable)

The allottees under the 10% Placement Facility have not been determined as at the date of this Notice but may include existing substantial Shareholders and/or new Shareholders who are not related parties or associates of a related party of the Company.

Further, if the Company is successful in acquiring new resource assets or investments, it is likely that the allottees under the 10% Placement Facility will be the vendors of the new resource assets or investments.

(e) The Company was previously granted approval for a 10% Placement Facility under LR7.1A at its Annual General Meeting held on 28 November 2019.

In accordance with LR7.3A.6, the Company provides the following information:

LR7.3A.6(a).

  • The total number of equity securities issued in the 12 months preceding the date of the meeting amounted to 78,019,408 representing 15% of the total number of Equity Securities on issue. These were issued under LR7.1, the 15% placement facility, and in compliance with LR 10.11.

LR7.3A.6(b).

  • The 78,019,408 ordinary shares were made in three separate issues.

  • The above shares were issued as fully paid ordinary shares, ranking equally with existing shares. Quotation on the ASX was sought and obtained.

  • 78,019,408 shares were issued to Sophisticated and Professional Investors as shown in Table 2 below and none of those allottees were related parties.

Table 2

Table 2
Date Applicant Shares
applied
for LR7.1
(15%)
Shares
Applied
for
LR7.1A
(10%)
Shares
issued
in compli-
ance with
LR10.11
Price
($)
Discount/
Premium
to market
price
Cash
con-
sideration
$
Use
of
funds
20/11/2019 Sophisticated and
Professional
Investors
as
follows:
Graham Forward
Pty Ltd, Peloton
Pty Ltd, Cen Pty
Ltd
12,000,000* 0.0025 16.66%
discount
$30,000 100%
resource
develop-
ment and
Corporate
costs
12/03/2020 Sophisticated and
Professional
Investors
as
follows:
Michael
Damian
Murphy, Cen Pty
Ltd,
Armuk
Pty
Ltd, JERD Pty Ltd.
35,333,333* 0.0015 25%
discount
$53,000 100%
resource
develop-
ment and
Corporate
costs
08/07/2020 Sophisticated and
Professional
Investors
as
follows:
Geoffrey
Allen
Bailey, Mrs Luye
Li, Benken Capital
Group Pty Ltd, Mr
Ben
Michael
Faulkner, Cen Pty
Ltd
30,686,075* 0.002 nil $61,372 100%
resource
develop-
ment and
Corporate
costs
24/09/2020 Sophisticated and
Professional
Investors
as
advised to ASX
52,000,000 0.008 23%
discount
$416,000 100% to
resource
develop-
ment and
Corporate
costs
TOTAL 78,019,408 52,000,000

18

* Ratification of this issue being sought under Resolution 2, 3 and 4 of this Annual General Meeting.

(f) A voting exclusion statement is included in the Notice of Meeting. At the date of the Notice of Meeting, the Company has not approached any particular existing Shareholder or security holder or an identifiable class of existing security holder to participate in the issue of the Equity Securities. No existing Shareholder's votes will therefore be excluded under the voting exclusion in the Notice.


19

Schedule 1 – Terms and Conditions of Placement Options

(a) (Entitlement) The Placement Options (Options) entitle the holder to subscribe for one Share upon the exercise of each Option at the exercise price of $0.015.

(b) (Expiry Date) The Options will expire at 5.00pm (WAST) on 31 May 2023.

(c) (Exercise period) The Options can be exercised at any time from their date of issue to the Expiry Date of 31 May 2023.

(d) (Notice of exercise) The Options may be exercised by notice in writing to the Company and payment of the Exercise Price for each Option being exercised. Any notice of exercise of an Option received by the Company will be deemed to be a notice of the exercise of that Option on the date the notice is received.

(e) (Shares issued on exercise) Shares issued on exercise of the Options will rank equally with the existing Ordinary Fully Paid Shares of the Company.

(f) (Quotation of Shares upon Option exercise) Application will be made by the Company to ASX for official quotation of the Shares issued upon the exercise of the Options.

(g) (Timing of Issue of Shares) After funds have been cleared relative to the exercise of options the Company will as soon as possible issue the Shares and endeavour to obtain quotation of the shares on ASX no later than 10 days from the date of exercise of the options.

(h) (Participation in new issues) There are no entitlement rights attached to the Options. Any option holder holding only options in the Company will not be entitled to participate in new issues of capital offered to Shareholders of the Company during the currency of the Options. If the Company makes an issue of Shares pro rata to existing Shareholders, there will not be an adjustment to the Option Exercise Price of $0.015.

(i) (Bonus issues of Shares) If the Company makes a bonus issue of Shares or other securities to existing Shareholders (other than an issue in lieu or in satisfaction, of dividends or by way of dividend reinvestment) the option holder will be entitled to the bonus entitlement of additional shares upon the exercise of the options and the exercise price of those options will remain at $0.015.

(j) (Adjustments for reorganisation) In the event of any reorganisation of capital of the Company, the rights of the option holder will be changed to the extent necessary to comply with the Listing Rules applying to the reorganisation of capital at the time of reorganisation.

(k) (Quotation of the Options) Application will be made to ASX for Official Quotation of the Options within seven days of the closing date of any required Prospectus.

(l) (Options transferable) The Options are freely transferable.

(m) (Lodgement Instructions) The Application Form for shares on exercise of the Options, together with the appropriate remittance, should be lodged with the Company or the Company’s Share Registry. Please note that Cheques must be in Australian currency, made payable to the Company and crossed "Not Negotiable".

.

ACN: 009 067 476 8/800 Albany Hwy East Victoria Park Western Australia 6101 Tel: (61 8) 9355 0123 Fax: (61 8) 9355 1484 [email protected] www.mountburgess.com

20

LODGE YOUR PROXY APPOINTMENT ONLINE

==> picture [182 x 67] intentionally omitted <==

ONLINE PROXY APPOINTMENT www.advancedshare.com.au/investor-login MOBILE DEVICE PROXY APPOINTMENT Lodge your proxy by scanning the QR code below, and enter your registered postcode. It is a fast, convenient and a secure way to lodge your vote.

IMPORTANT NOTE:

the Company intends to conduct its AGM by way of a live video conference. Shareholders are strongly encouraged to vote by lodging a directed proxy appointing the Chair as early as possible and in any event prior to the cut-off for proxy voting as set out in the Notice of Meeting.

2020 ANNUAL GENERAL MEETING PROXY FORM

I/We being shareholder(s) of Mount Burgess Mining N.L. and entitled to attend and vote hereby:

APPOINT A PROXY

The Chairman of  PLEASE NOTE: If you leave the section blank, the OR the meeting Chairman of the Meeting will be your proxy.

or failing the individual(s) or body corporate(s) named, or if no individual(s) or body corporate(s) named, the Chairman of the Meeting, as my/our proxy to act generally at the meeting on my/our behalf, including to vote in accordance with the following directions (or, if no directions have been given, and to the extent permitted by law, as the proxy sees fit), at the Annual General Meeting of the Company to be held virtually on 30 November 2020 at 2.30 pm Perth time and at any adjournment or postponement of that Meeting.

Chairman authorised to exercise undirected proxies on remuneration related resolutions: Where I/we have appointed the Chairman of the Meeting as my/our proxy (or the Chairman becomes my/our proxy by default), I/we expressly authorise the Chairman to exercise my/our proxy on Resolution 1 (except where I/we have indicated a different voting intention below) even though this resolution is connected directly or indirectly with the remuneration of a member(s) of key management personnel, which includes the Chairman. I/we acknowledge the Chairman of the Meeting intends to vote all undirected proxies available to them in favour of each Item of Business.

VOTING DIRECTIONS

2020 ANNUAL GENERAL MEETING PROXY FORM
I/We being shareholder(s) of Mount Burgess Mining N.L. and entitled to attend and vote hereby:
STEP 1 APPOINT A PROXY
The Chairman of
the meeting
OR
PLEASE NOTE:If you leave the section blank, the
Chairman of the Meeting will be your proxy.
or failing the individual(s) or body corporate(s) named, or if no individual(s) or body corporate(s) named, the Chairman of the Meeting, as my/our
proxy to act generally at the meeting on my/our behalf, including to vote in accordance with the following directions (or, if no directions have been
given, and to the extent permitted by law, as the proxy sees fit), at the Annual General Meeting of the Company to be heldvirtually on 30
November 2020 at 2.30 pm Perth timeand at any adjournment or postponement of that Meeting.
Chairman authorised to exercise undirected proxies on remuneration related resolutions:Where I/we have appointed the Chairman of the
Meeting as my/our proxy (or the Chairman becomes my/our proxy by default), I/we expressly authorise the Chairman to exercise my/our proxy
on Resolution 1 (except where I/we have indicated a different voting intention below) even though this resolution is connected directly or indirectly
with the remuneration of a member(s) of key management personnel, which includes the Chairman. I/we acknowledge the Chairman of the
Meeting intends to vote all undirected proxies available to them in favour of each Item of Business.
VOTING DIRECTIONS
STEP 2 Resolutions
For
Against
Abstain*
1
Adoption of Remuneration Report


2
Ratification of Previous Issue of Shares – November 2019


3
Ratification of Previous Issue of Shares – March 2020


4
Ratification of Previous Issue of Shares – July 2020


5
Re-election of Director- Mr Chris Campbell-Hicks


6
Issue of Shares to a Director in lieu of Directors’ Fees Ms K A Clark


7
Issue of Shares to a Director in lieu of Directors’ Fees Ms S Chau


8
Issue of Shares to a Director in lieu of Directors’ Fees Ms J Forrester


9
Issue of Shares to a Director in lieu of Directors’ Fees Mr C Campbell-Hicks


10
Issue of Shares to a Director in lieu of Directors’ Fees Mr H Warries


11
Issue of Issue of Placement Options


12
Approval of 10% Placement Facility (Special Resolution)


* If you mark the Abstain box for a particular Resolution, you are directing your proxy not to vote on your behalf on a poll and your votes will
not be counted in computing the required majority on a poll.
STEP 3 SIGNATURE OF SHAREHOLDERS – THIS MUST BE COMPLETED
Shareholder 1(Individual)
Joint Shareholder 2(Individual)
Joint Shareholder 3(Individual)
Sole Director and Sole Company Secretary
Director/CompanySecretary (Delete one)
Director
This form should be signed by the shareholder. If a joint holding, all the shareholder should sign. If signed by the shareholder’s attorney, the power
of attorney must have been previously noted by the registry or a certified copy attached to this form. If executed by a company, the form must be
executed in accordance with the company’s constitution and the Corporations Act 2001 (Cth).
Email Address
Please tick here to agree to receive communications sent by the company via email. This may include meeting notifications, dividend
remittance, and selected announcements.

COVID-19: MOUNT BURGESS MINING N.L. ANNUAL GENERAL MEETING

A live webcast and electronic voting via www.advancedshare.com.au/virtual-meeting will be offered to allow Shareholders to listen to the Meeting and vote online. Please refer to the Meeting ID and Shareholder ID on your personalised proxy form to login to the website. Shareholders may submit questions ahead of the Meeting via the portal from 1 November 2020.

HOW TO COMPLETE THIS SHAREHOLDER PROXY FORM

CHANGE OF ADDRESS

This form shows your address as it appears on Company’s share register. If this information is incorrect, please make the correction on the form. Shareholders sponsored by a broker should advise their broker of any changes.

APPOINTMENT OF A PROXY

If you wish to appoint the Chairman as your proxy, mark the box in Step 1. If you wish to appoint someone other than the Chairman, please write that person’s name in the box in Step 1. A proxy need not be a shareholder of the Company. A proxy may be an individual or a body corporate.

DEFAULT TO THE CHAIRMAN OF THE MEETING

If you leave Step 1 blank, or if your appointed proxy does not attend the Meeting, then the proxy appointment will automatically default to the Chairman of the Meeting.

VOTING DIRECTIONS – PROXY APPOINTMENT

You may direct your proxy on how to vote by placing a mark in one of the boxes opposite each resolution of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any resolution by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on a given resolution, your proxy may vote as they choose to the extent they are permitted by law. If you mark more than one box on a resolution, your vote on that resolution will be invalid.

PROXY VOTING BY KEY MANAGEMENT PERSONNEL

If you wish to appoint a Director (other than the Chairman) or other member of the Company’s key management personnel, or their closely related parties, as your proxy, you must specify how they should vote on Resolution 1, by marking the appropriate box. If you do not, your proxy will not be able to exercise your vote for Resolution 1.

PLEASE NOTE: If you appoint the Chairman as your proxy (or if they are appointed by default) but do not direct them how to vote on a resolution (that is, you do not complete any of the boxes “For”, “Against” or “Abstain” opposite that resolution), the Chairman may vote as they see fit on that resolution.

APPOINTMENT OF A SECOND PROXY

You are entitled to appoint up to two persons as proxies to attend the meeting and vote on a poll. If you wish to appoint a second proxy, an additional Proxy Form may be obtained by telephoning Advanced Share Registry Limited or you may copy this form and return them both together.

To appoint a second proxy you must:

  • (a) On each Proxy Form state the percentage of your voting rights or number of shares applicable to that form. If the appointments do not specify the percentage or number of votes that each proxy may exercise, each proxy may exercise half your votes. Fractions of votes will be disregarded; and

  • (b) Return both forms together.

COMPLIANCE WITH LISTING RULE 14.11

In accordance to Listing Rule 14.11, if you hold shares on behalf of another person(s) or entity/entities or you are a trustee, nominee, custodian or other fiduciary holder of the shares, you are required to ensure that the person(s) or entity/entities for which you hold the shares are not excluded from voting on a resolution where there is a voting exclusion. Listing Rule 14.11 requires you to receive written confirmation from the person or entity providing the voting instruction to you and you must vote in accordance with the instruction provided.

CORPORATE REPRESENTATIVES

If a representative of a nominated corporation is to attend the meeting the appropriate “Certificate of Appointment of Corporate Representative” should be produced prior to admission in accordance with the Notice of Meeting. A Corporate Representative Form may be obtained from Advanced Share Registry.

SIGNING INSTRUCTIONS ON THE PROXY FORM

Individual:

Where the holding is in one name, the security holder must sign.

Joint Holding:

Where the holding is in more than one name, all of the security holders should sign.

Power of Attorney:

If you have not already lodged the Power of Attorney with Advanced Share Registry, please attach the original or a certified photocopy of the Power of Attorney to this form when you return it.

Companies:

Where the company has a Sole Director who is also the Sole Company Secretary, this form must be signed by that person. If the company (pursuant to section 204A of the Corporations Act 2001) does not have a Company Secretary, a Sole Director can sign alone. Otherwise this form must be signed by a Director jointly with either another Director or a Company Secretary. Please sign in the appropriate place to indicate the office held.

LODGE YOUR PROXY FORM

This Proxy Form (and any power of attorney under which it is signed) must be received at an address given below by 2.30 pm Perth time on 28 November 2020, being not later than 48 hours before the commencement of the Meeting. Proxy Forms received after that time will not be valid for the scheduled meeting.

==> picture [11 x 11] intentionally omitted <==

ONLINE PROXY APPOINTMENT www.advancedshare.com.au/investor-login BY MAIL Advanced Share Registry Limited 110 Stirling Hwy, Nedlands WA 6009; or PO Box 1156, Nedlands WA 6909 BY FAX +61 8 6370 4203 BY EMAIL [email protected] IN PERSON Advanced Share Registry Limited 110 Stirling Hwy, Nedlands WA 6009 ALL ENQUIRIES TO Telephone: +61 8 9389 8033

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

==> picture [11 x 11] intentionally omitted <==

By lodging your proxy votes, you confirm to the company that you are in compliance with Listing Rule 14.11.